Indian Pharma Market Booms: 9.5% Growth in March 2024
Leading therapies like cardiac, anti-infectives, and gastro-intestinal recorded robust volume growth in MAT figures, constituting 37.5% of IPM.
Source: indiainfoline.com
Stay updated with breaking news from Alembic Pharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading therapies like cardiac, anti-infectives, and gastro-intestinal recorded robust volume growth in MAT figures, constituting 37.5% of IPM.
/PRNewswire/ -- The "Alzheimer's Therapeutics Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering. The Alzheimer's Therapeutics...